Dr. Aitken is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
Ann Arbor, MI 48109Phone+1 734-936-5582Fax+1 734-615-2109
Education & Training
- University of MichiganFellowship, Hematology and Medical Oncology, 2023
- University of MichiganResidency, Internal Medicine, 2021 - 2023
- McGovern Medical School at UTHealthClass of 2021, MD
- University of Texas MD Anderson Cancer Center UT Health Graduate School of Biomedical SciencesPhD, Immunology , 2020
Publications & Presentations
PubMed
- 4 citationsHeterogeneous nuclear ribonucleoprotein K is overexpressed in acute myeloid leukemia and causes myeloproliferation in mice via alteredsplicing.Marisa J L Aitken, Prerna Malaney, Xiaorui Zhang, Shelley M Herbrich, Lauren Chan
NAR Cancer. 2022-12-01 - 18 citationsTargeting the NRF2/HO-1 Antioxidant Pathway in FLT3-ITD-Positive AML Enhances Therapy Efficacy.Sankaranarayan Kannan, Mary E Irwin, Shelley M Herbrich, Tiewei Cheng, LaNisha L Patterson
Antioxidants. 2022-04-05 - 18 citationsAXL/MERTK inhibitor ONO-7475 potently synergizes with venetoclax and overcomes venetoclax resistance to kill FLT3-ITD acute myeloid leukemia.Sean M. Post, Huaxian Ma, Prerna Malaney, Xiaorui Zhang, Marisa J.L. Aitken
Haematologica. 2021-11-04
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: